Indication
Subacute bursitis
Subacute bursitis refers to an intermediate stage of inflammation affecting one or more bursae—the synovial fluid-filled sacs that reduce friction between bones, tendons, muscles, and skin. Read more about Subacute bursitis
102 drugs 74 manufacturers
Drugs that treat it
Common Subacute bursitis therapies.
DEXAMETHASONE
DEXLYT (dexamethasone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSubacute bursitis refers to an intermediate stage of inflammation affecting one or more bursae—the synovial fluid-filled sacs that reduce friction between bones, tendons, muscles, and skin.
This musculoskeletal condition commonly impacts adults experiencing prolonged joint strain, repetitive microtrauma, crystalline deposition, or secondary complications following an acute flare.
Clinically and pathophysiologically, it is defined by persistent bursal synovial proliferation, fluid effusion, localized pain, and restricted joint mobility that extend beyond the initial acute period of several days without yet displaying the extensive fibrosis or permanent structural thickening characteristic of chronic disease.
- nih.gov
Subacute bursitis refers to an intermediate stage of inflammation affecting one or more bursae—the synovial fluid-filled sacs that reduce friction between bones, tendons, muscles, and skin This musculoskeletal condition commonly impacts adults experiencing prolonged joint strain, repetitive microtrauma, crystalline deposition, or secondary complications following an acute flare Clinically and pathophysiologically, it is defined by persistent bursal synovial proliferation, fluid effusion, localiz...
- msdmanuals.com
Subacute bursitis refers to an intermediate stage of inflammation affecting one or more bursae—the synovial fluid-filled sacs that reduce friction between bones, tendons, muscles, and skin This musculoskeletal condition commonly impacts adults experiencing prolonged joint strain, repetitive microtrauma, crystalline deposition, or secondary complications following an acute flare Clinically and pathophysiologically, it is defined by persistent bursal synovial proliferation, fluid effusion, localiz...
- nih.gov
Clinically and pathophysiologically, it is defined by persistent bursal synovial proliferation, fluid effusion, localized pain, and restricted joint mobility that extend beyond the initial acute period of several days without yet displaying the extensive fibrosis or permanent structural thickening characteristic of chronic disease
Personalize your experience
Follow Subacute bursitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.